Foghorn Therapeutics Inc (FHTX)
EBITDA Growth
59.26%
Quarterly · Period ending:
FHTX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported59.26%period ending
Latest reported59.26%period ending
FHTX Quarterly EBITDA YoY % (-75.93% → 59.26%)
Year-over-year change
High-resolution chart · PNG
FHTX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 59.2567% | |
| -9.052% | |
| -11.3115% | |
| 18.4458% | |
| 27.1211% | |
| 25.5324% | |
| 11.877% | |
| -44.3067% | |
| 15.2734% | |
| 16.8152% | |
| 24.1458% | |
| 48.8767% | |
| -4.435% | |
| -11.3627% | |
| -0.4694% | |
| -0.8333% | |
| -21.354% | |
| -16.7502% | |
| -40.4196% | |
| -38.0235% | |
| -42.9638% | |
| -66.3665% | |
| -33.5529% | |
| -39.8236% | |
| -35.694% | |
| -19.4153% | |
| -75.9331% | |
| -75.9331% |